|
Pharmacokinetic Type
|
Species
|
Peak in hours
|
Duration in hours
|
|
Ultra-fast-acting
Insulin lispro, aspart, glulisine
|
Human, modified
|
0.25-0.50
|
3.0-4.0
|
|
Fast-acting
Insulin injection USP (regular,
crystalline zinc)
|
Human, pork
|
0.50-3.0
|
5.0-7.0
|
|
Intermediate-acting
NPH Insulin (isophane insulin
suspension USP)
Lente Insulin (insulin zinc
suspension USP)
|
Human, pork
|
8.0-12.0
|
18.0-24.0
|
|
Human, pork
|
8.0-12.0
|
18.0-24.0
|
|
|
Long-acting
Untralente (insulin zinc
suspension extended USP)
Protamine Zinc insulin
|
Human
|
8.0-16.0
|
18.0-28.0
|
|
Human
|
8.0-16.0
|
18.0-28.0
|
|
|
Untra-long-acting
Insulin glargine
|
Human, modified
|
No peak
|
>24.0
|
Sunday, February 10, 2013
Characteristics of Insulin Preparation
